Tag: received

FSD has not received further reports of lift incidents due to voltage dip ************************************************************************* Attention TV and radio duty announcers:      Please broadcast the following special announcement as soon as possible, and repeat it at suitable intervals:      A voltage dip occurred in New Territories and Kowloon districts at 12.28pm today (March 30), resulting in cases of person being shut in lift. The Fire Services Department has not received any further reports of lift incidents due to voltage dip.

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the excellent result in the “All-Asia Executive Team Rankings 2023” under the category of Healthcare, Pharma & Biotech organized by Institutional Investor, an international magazine. The Group is delighted recognize as The Most Honoured Company (Healthcare, Pharma & Biotech) in the division – Mid & Smallcap and Asia (excluding mainland China), which represents recognition of the Group’s impressive performance by the investors and the market. Recognized as an authoritative ... Read more

 Earlier this year, Tammy Phan, CEO and Founder of Luxe Du Jour, was recognized by SME Canadian Business Association Awards; Luxe Du Jour won Business of the Year. The Company hasn’t slowed down since constantly innovating and solving market problems. Luxe Du Jour is the newest go-to destination to connect handbag renters and lenders – think of it as the “Airbnb” of bags. It is an innovative way where you can become a borrower and rent out high-end authentic designer handbags or you can be a lender and make passive income off the bags you do not currently use and ... Read more

SinoMab BioScience Limited (“SinoMab” or the “Company”, together with its subsidiaries, the “Group”, stock code: 3681.HK), a Hong Kong-listed biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of innovative therapeutics for the treatment of immunological diseases, primarily mAb-based biologics, is pleased to announce that, the Company has received HK$8 million subsidy from the Hong Kong Science and Technology Parks Corporation (“HKSTP”), which is the highest subsidy amount in the Clinical Translational Catalyst (CTC) program of HKSTP. CTC program is offered by HKSTP Institute for Translational Research (ITR), the overarching aim is to provide a platform to transform Hong ... Read more

EC Healthcare (the “Company”, which together with its subsidiaries is referred to as the “Group”, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the excellent result in the “All-Asia Executive Team Rankings 2022” under the category of Healthcare & Pharmaceutical organized by Institutional Investor, an international magazine. The Group is delighted recognize as The Most Honoured Company (Healthcare & Pharmaceutical) in the division – Asia (excluding mainland China), which represents recognition of the Group’s impressive performance by the investors and the market. Recognized as an authoritative ranking by industries, “All-Asia Executive Team ... Read more